Мобильная версия

Доступно журналов:

3 288

Доступно статей:

3 891 637

 

Скрыть метаданые

Автор Correia, Maria Almira
Автор Sadeghi, Sheila
Автор Mundo-Paredes, Eduardo
Дата выпуска 2005
dc.description ▪ Abstract  The hepatic cytochromes P450 (P450s) are monotopic endoplasmic reticulum (ER)-anchored hemoproteins engaged in the enzymatic oxidation of a wide variety of endo- and xenobiotics. In the course of these reactions, the enzymes generate reactive O2 species and/or reactive metabolic products that can attack the P450 heme and/or protein moiety and structurally and functionally damage the enzyme. The in vivo conformational unraveling of such a structurally damaged P450 signals its rapid removal via the cellular sanitation system responsible for the proteolytic disposal of structurally aberrant, abnormal, and/or otherwise malformed proteins. A key player in this process is the ubiquitin (Ub)-dependent 26S proteasome system. Accordingly, the structurally deformed P450 protein is first branded for recognition and proteolytic removal by the 26S proteasome with an enzymatically incorporated polyUb tag. P450s of the 3A subfamily such as the major human liver enzyme CYP3A4 are notorious targets for this process, and they represent excellent prototypes for the understanding of integral ER protein ubiquitination. Not all the participants in hepatic CYP3A ubiquitination and subsequent proteolytic degradation have been identified. The following discussion thus addresses the various known and plausible events and/or cellular participants involved in this multienzymatic P450 ubiquitination cascade, on the basis of our current knowledge of other eukaryotic models. In addition, because the detection of ubiquitinated P450s is technically challenging, the critical importance of appropriate methodology is also discussed.
Формат application.pdf
Издатель Annual Reviews
Копирайт Annual Reviews
Название CYTOCHROME P450 UBIQUITINATION: Branding for the Proteolytic Slaughter?
DOI 10.1146/annurev.pharmtox.45.120403.100127
Print ISSN 0362-1642
Журнал Annual Review of Pharmacology and Toxicology
Том 45
Первая страница 439
Последняя страница 464
Аффилиация Correia, Maria Almira; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, California 94143-0450; email: mariac@itsa.ucsf.edu , sadeghi@itsa.ucsf.edu , eduardo@itsa.ucsf.edu

Скрыть метаданые